Mr Smith expressed his disapproval of the anti-counterfeit medicines legislation during the annual Sigma conference in Cebu in the Philippines...
It is “critical” that the government resists any US proposals to “change patent or exclusivity provisions” that could delay the entry of generic and...
The system of reimbursement from the NHS incentivises pharmacy owners to buy generics as cheaply as possible, allowing them to make a profit, while...
If Labour won the election, it would set up these companies to save “our health service money and save lives”, leader Jeremy Corbyn claimed at his...
“A lot of people with epilepsy are stocking up” on medicines, according to Epilepsy Society medical director Ley Sander, with some requesting an “...
At one level, the UK medicines supply chain – from manufacturer to wholesaler to community pharmacies – is a relatively simple one. The originator of...
It was good to see the letter sent to C+D by the pharmacy minister, Seema Kennedy, last week. We all broadly welcome the commitment to an expanded...
As one of the UK’s largest generics manufacturers, the suspension of Bristol Laboratories’ licence in 2017 prompted severe shortages, which the...
The Pharmaceutical Services Negotiating Committee (PSNC) director of pharmacy funding Mike Dent told C+D that, “while there have always been...
The Department of Health and Social Care (DH) was granted powers in July 2017 to impose changes to medicine prices when it thinks “inappropriate...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter